Published in Telemedicine Week, June 1st, 2004
Robert Wake, vice president of engineering, stated, "This patent, the Canadian equivalent of U.S. Letters patent 5,952,664, broadly covers the optical imaging of fluorescent compounds. This will be extremely valuable in the future, as work by collaborators, such as Schering, AG, and others, results in developing cancer-specific fluorophores. Once these fluorophores are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week